Streetbeat News

Stock Prices

SPY

The Consumer Price Index (CPI) year-on-year for June came in at 3.0%, lower than the expected 3.1% and the previous month's 4.0%.

Portfolio Pulse from Benzinga Newsdesk

July 12, 2023 | 12:30 pm

DIA

IWM

QQQ

SPY

The Core CPI (YoY) for June came in at 4.8%, lower than the estimated 5%. This could impact the performance of ETFs like DIA, IWM, QQQ, and SPY.

Portfolio Pulse from Benzinga Newsdesk

July 12, 2023 | 12:30 pm

SPY

The Consumer Price Index (CPI) for June increased by 0.2%, which is lower than the expected 0.3% and higher than the prior 0.1%.

Portfolio Pulse from Benzinga Newsdesk

July 12, 2023 | 12:30 pm

ANGO

AngioDynamics Inc reported Q4 FY23 adjusted EPS of $0.02, in line with consensus and higher than $0.01 a year ago. Q4 sales increased 4.7% Y/Y to $91.07 million, beating the analyst consensus of $90.3 million. However, the company reported a Q4 loss of $21.46 million, much wider than $6.27 million reported a year ago. The company's shares are down 2.52% in premarket trading.

Portfolio Pulse from Vandana Singh

July 12, 2023 | 12:29 pm

APA

Goldman Sachs analyst Neil Mehta has downgraded APA (NASDAQ:APA) from Neutral to Sell and lowered the price target from $35 to $30.

Portfolio Pulse from Benzinga Newsdesk

July 12, 2023 | 12:26 pm

TTOO

T2 Biosystems reported lower than expected preliminary Q2 sales of $2 million, causing its shares to trade lower.

Portfolio Pulse from Benzinga Newsdesk

July 12, 2023 | 12:26 pm

INCY

Incyte Corporation has announced positive topline results from its Phase 3 TRuE-AD3 study evaluating the safety and efficacy of ruxolitinib cream (Opzelura) in children with atopic dermatitis (AD). The study met its primary endpoint, showing significantly more patients treated with ruxolitinib cream achieved Investigator's Global Assessment Treatment Success than those treated with a non-medicated cream. The safety profile of ruxolitinib cream is consistent with previous data, and no new safety signals were observed. The long-term safety portion of the study will continue as planned.

Portfolio Pulse from Vandana Singh

July 12, 2023 | 12:23 pm

SPWR

Raymond James has upgraded SunPower's stock from Outperform to Strong and announced a $21 price target. This has resulted in SunPower shares trading higher.

Portfolio Pulse from Benzinga Newsdesk

July 12, 2023 | 12:21 pm

HLLY

Holley's shares are trading higher following positive analyst changes. B of A Securities upgraded the stock and raised its price target from $3.25 to $6. JP Morgan also upgraded the stock from Overweight to Neutral and announced a $7 price target.

Portfolio Pulse from Benzinga Newsdesk

July 12, 2023 | 12:20 pm

CVKD

SILK

Several stocks are experiencing significant pre-market trading movements. Cadrenal Therapeutics, Healthcare Triangle, FLJ Group, Enochian Biosciences, Eloxx Pharmaceuticals, Vivos Therapeutics, Data Storage Corporation, CBL International, Ascent Solar Technologies, and ImmuCell Corporation are among the gainers. Silk Road Medical, ShiftPixy, PainReform, Biodexa Pharmaceuticals, Adial Pharmaceuticals, WANG & LEE GROUP, CytoMed Therapeutics, Cingulate, Crown ElectroKinetics, and Purple Biotech are among the losers.

Portfolio Pulse from Lisa Levin

July 12, 2023 | 12:19 pm